Purple Biotech PPBT
NASDAQ PPBT
$1.15 +0.06 (+5.99%)
At close: Oct 21, 2026 · 4:00 PM EDT

Purple Biotech (PPBT) Income from Continuing Operations (2021 - 2023)

Updated

Purple Biotech's Income from Continuing Operations was -$4.86 million in Q4 2023, compared with -$6.04 million a year earlier.

Analysis

Purple Biotech (PPBT) Income from Continuing Operations (2021 - 2023) Analysis & Trends

For FY2023, Income from Continuing Operations at Purple Biotech came in at -$19.98 million.

  • In earlier years, Income from Continuing Operations was -$21.76 million in FY2022, -$17.83 million in FY2021, -$28.7 million in FY2020 and -$5.41 million in FY2019.
  • The Q4 2023 figure marks the highest quarterly Income from Continuing Operations since Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 5.53 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 3.62 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.51 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -10.50 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -246.00 Mn
10 Purple Biotech 537,659.78 -32.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -4.86 Mn
Dec 31, 2022 -6.04 Mn
Sep 30, 2022 4.85 Mn
Jun 30, 2022 3.55 Mn
Mar 31, 2022 7.32 Mn
Dec 31, 2021 -4.75 Mn
Sep 30, 2021 3.00 Mn
Jun 30, 2021 3.65 Mn
Mar 31, 2021 6.43 Mn
API Access

Purple Biotech Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=PPBT&period=max&api_key=YOUR_API_KEY